Micrographia Bio is a developer of a drug discovery platform. They are designed to accelerate biomedical innovation and eradicate the commercial barrier to developing new medicines via artificial intelligence-enabled bioimage analysis. They focus on the autonomous assessment of the therapeutic mechanism of action as well as combining novel methods for multiplexed microscopy imaging with machine-intelligent computer vision software to understand the true nature of the therapeutic activity, enabling healthcare professionals to resolve the true molecular functions of potential therapeutics.